OptiMesh Multiplanar Expandable Interbody Fusion System
FDA 510(k)Class II (US FDA 510(k))
Identifiers
- 510(k) Number
- K251302 FDA 510(k)
- FDA Product Code
- OQB FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 888.3085 FDA 510(k)
- Regulation Number
- 888.3085 FDA 510(k)
- Advisory Committee
- Orthopedic FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The OptiMesh Multiplanar Expandable Interbody Fusion System is an intervertebral body graft containment device. It is a porous mesh container knitted from polyester yarn made of polyethylene terephthalate (PET) thread and is designed to contain bone graft as an adjunct to fusion in instrumented lumbar fusion procedures.
The device is supplied as a single implant intended for use in lumbar fusion procedures, accommodating multiple approaches including open, MIS TLIF, ultra-MIS (OptiLIF), and endoscopic fusion (OptiLIF Endo). It is classified as a Class II medical device under FDA regulation, with product code OQB and regulation number 888.3085, and has received traditional 510(k) clearance (K251302) as substantially equivalent to a predicate device.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: OptiMesh - Spineology, PDF OptiMesh® Multiplanar Expandable Interbody Fusion System, OptiMesh Multiplanar Expandable Interbody Fusion System
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K251302 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Spineology Inc.
- FDA Applicant
- Spineology, Inc.
Sources (1)
- FDA 510(k) K251302 24 fields · synced Sep 26, 2026